Assessment of using Acoustic Pulse Technology (APT) at the dry-off - - PowerPoint PPT Presentation

assessment of using acoustic pulse technology apt at the
SMART_READER_LITE
LIVE PREVIEW

Assessment of using Acoustic Pulse Technology (APT) at the dry-off - - PowerPoint PPT Presentation

Assessment of using Acoustic Pulse Technology (APT) at the dry-off period for the treatment and prevention of Mastitis Gabriel Leitner, Eddy Papirov, Sala Shefy Armenta, Israel 1 Antibiotics: Current practice and its consequences The


slide-1
SLIDE 1

1

Assessment of using Acoustic Pulse Technology (APT) at the dry-off period for the treatment and prevention of Mastitis

Gabriel Leitner, Eddy Papirov, Sala Shefy Armenta, Israel

slide-2
SLIDE 2

Antibiotics: Current practice and it’s consequences

2

v The dry-off period is an important resting period between lactations v During that period, invasion of bacteria could occur, leading to mastitis in the following lactation v Long-term antibiotic use is currently being practiced to treat intra- mammary infections and protection against new infections v The widespread use of antibiotics causes the development of anti- microbial resistance (AMR) which poses a major public health hazard v Consequently, health authorities are prohibiting the widespread use

  • f these drugs, leaving farmers with no available solution for

treating and preventing mastitis while leading to greater financial losses

slide-3
SLIDE 3

New Treatment Option: APT – Acoustic Pulse Technology

3

v APT – also known as shockwave therapy

  • is

a multidisciplinary method that has been used over the last 35 years in

  • rthopaedics,

physiotherapy, sports medicine, urology and veterinary medicine v Shockwaves are mechanical waves featuring a steep pressure rise in nano seconds range v A compressive phase causing a tissue strain (macro effect) followed by tensile phase causing cavitation (micro effect)

slide-4
SLIDE 4

Biological effect of APT (Low Energy Shock Waves)

4

  • Shear stress activates endothelial nitric oxide synthase

(ENOS) to generate Nitric Oxide

  • Shockwave-elicited mechano-transduction to elevate

endothelial progenitor cells (EPCs) through transformation from bone marrow-derived mononuclear cells (BMDMNCs), and EPC mobilization

  • Shockwave also triggers the expression of stromal cell-

derived factor 1 (SDF-1) that facilitates homing of EPCs to the ischemic site.

  • Shockwave also induces the expression of vascular

endothelial growth factors (VEGF) that contributes to angiogenesis.

Wang C-J, Schaden W, Ko J-Y (eds): Shockwave Medicine. Transl Res Biomed. Basel, Karger, 2018, vol 6, pp 102–108

Schematic illustration

  • f

anti-inflammatory and pro- angiogenic effects of extracorporeal shockwave

slide-5
SLIDE 5

APT in dairy farming

v APT’s acoustic pulses are generated via ballistic impact powered by high pressurized air v The APT device generates low intensity pulses at therapeutic energy flux density covering a large area of the shape of truncated cone at 50 mm x 150mm x 300mm

ARMENTA’s APT

slide-6
SLIDE 6

Location Farms Cows sub clinical Cows clinical Total APT Control APT Control APT Israel 8 331 + 21 60 +29 22 16 374 USA 3 100 41 9 10 109 France 9 14 14 7 21 Italy 3 13 4 1 1 14 Total 23 518

Cows with clinical and subclinical mastitis has shown bacterial elimination, increased milk yield and lower SCC.

Previous experience with APT

slide-7
SLIDE 7

APT=257 Control=55

7

Recovered Recovered Summary of results: Subclinical

slide-8
SLIDE 8

APT=22 Control=26

8

Recovered Recovered Summary of results: Clinical

slide-9
SLIDE 9

vThe aim of this study was to evaluate the effect of APT on cows during the dry period as an alternative to current dry cow therapies. vThe aim of this study was to evaluate the effect of APT on cows during the dry period as an alternative to current dry cow therapies.

slide-10
SLIDE 10

10

Dry -off Quarter CMT and Bacteriology

  • (45-35) d

Partum APT 30 60 90 DHI + Daly MY

Fifty cows, APT and control, were treated during dry-off periods, 4-5 weeks before parturition. Cows were paired according to lactation, daily milk yield, DIM, SCC, history

  • f infection, bacteriology and number of infected quarters.

In each pair, one cow was then assigned to APT and the second to control.

Study layout

slide-11
SLIDE 11
  • SCC in the APT group was 53%

lower post treatment compared to the same period pre treatment

  • SCC in the control group was 54%

higher post treatment compared to the same period pre treatment 100 200 300 400 500

APT Control

Pre

Post

Pre Post

220 vs. 101 277 vs. 427

SCC (1000) Average SCC (x1000) during the first 100 d of the lactation pre the dry period and that of the current one

Results

slide-12
SLIDE 12

27% vs. 29% 13.6% vs. 2% 3.3% vs. -10.4% 1.3% vs. -3.6%)

Overall change (Kg) in Milk Yield

  • Milk yield in the APT group was 5%

to 15% higher (>Lac 1) than in the control group

  • 15.0%
  • 5.0%

5.0% 15.0% 25.0% 35.0%

Lac 1 to 2 Lac 2 to 3 Lac 3 to 4 Lac 4,5 to 5,6

4200 4300 4400 4500 4600 4700 4800 4900 5000 APT Control

Pre Post Pre Post

0.8% 10.2%

Average different in Milk yield during the first 100 d of the lactation

P<0.05 NS

slide-13
SLIDE 13

13

v Estimating losses of clinical mastitis is straightforward: the infection is visible and requires treatment due to animal welfare. v Dealing with subclinical mastitis presents different challenges because in many of the cows there are no recognizable symptoms and the milk appears normal. Calculations of subclinical mastitis include various costs, such as: diagnostics of the infecting agent, veterinary services, medication, labor, discarded milk, decrease in milk production, premature culling and

  • mortality. The infection is not visible and the cost involved in treatment

during the lactation is too high. Despite many years of efforts to control mastitis, this infection is still one of the leading causes of economic losses to the dairy industry worldwide

Discussion

.

slide-14
SLIDE 14

14

v Acoustic pulse therapy (APT) opens an opportunity for treating subclinical mastitis during lactation, increasing the possibility of higher MY and quality and may lead to reducing the need for dry therapy.

Discussion

v The new APT treatment of clinical and subclinical mastitis can:

  • 1. significantly reduce the use of antibiotics;
  • 2. significantly reduce milk discarded during treatment;
  • 3. can be used to treat subclinical mastitis during lactation;
  • 4. can improve milk quantity and quality during the lactation, probably due to the

increased healing process of the damaged tissues;

  • 5. can decrease culling of subclinical mastitis cows due to low milk production and low

milk quality.

  • 6. ATP can be an alternative treatment during dry period
slide-15
SLIDE 15

15

Discussion

.

  • Therefore, cow longevity in the cowshed can be increased and forced

culling can be reduced.

  • Thus, the percent of replacement heifers will be reduced and milk

production will be increased, as older cows produce more milk than young

  • nes (+15%).
  • Holding fewer cows can significantly reduce the use of antibiotics;

producing the same quantity of milk, saving food, lowering treatment expenses and labor and obtaining higher milk production.

  • Repeated treatments can also increase recovery success for SCC and

microbial improvement.

slide-16
SLIDE 16

Thanks

Gabriel Leitner, David Zilberman , Eduard Papirov, Sela Shefy. 2018 Assessment of Acoustic Pulse Therapy (APT), a non-antibiotic treatment for dairy cows with clinical and subclinical mastitis. PLoS One.

slide-17
SLIDE 17

Dairy Farm Challenges During Lactation

Clinical Mastitis: Sub-Clinical Mastitis: Low Yield Heifers: Dry-period:

Sub-clinical mastitis, identified by high SCC (>250,000 cells/ml), could reduce milk production by 10%-15% and can leads to premature culling. Low yield heifers could reach breakeven point sooner in the lactation curve and shorten the lactation period (premature culling) Loss of milk during clean-up period from antibiotics followed by reduced milk yield. Some cases ends up in culling preventing future milk production. Risk of entering into the next lactation with infection that will reduce overall milk production throughout the lactation period